Immunomodulators Market Worth US$ 263.9 Billion by 2027 | Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company
According to the latest report by IMARC Group, titled “ Immunomodulators Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ”, the global immunomodulators market size reached US$ 187.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 263.9 Billion by 2027, exhibiting a growth rate (CAGR) of 5.76% during 2022-2027. Immunomodulators Market Size 2022-2027 Market Outlook: Immunomodulators refer to a group of drugs that are commonly prescribed to modify an immune response against immunodeficiency, infectious diseases and alterations in antibody transfer. These medicines are used for the treatment of asthma, cancer, tumors and autoimmune disorders. Some of these drugs include cytokines, levamisole, monoclonal antibodies and Bacillus Calmette-Guerin (BCG). Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Cli...